Kazia Therapeutics Limited (KZIA)
NASDAQ: KZIA · Real-Time Price · USD
14.22
+0.30 (2.16%)
Jun 26, 2026, 4:00 PM EDT - Market closed
Kazia Therapeutics Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash & Equivalents | 34.96 | 39.94 | 1.66 | 5.24 | 7.36 | 27.59 |
Cash & Short-Term Investments | 34.96 | 39.94 | 1.66 | 5.24 | 7.36 | 27.59 |
Cash Growth | 36.59% | 2309.50% | -68.38% | -28.80% | -73.32% | 214.78% |
Accounts Receivable | 7.3 | 4.51 | 3.9 | 3.9 | 0.09 | 0.08 |
Inventory | 6.19 | 6.91 | - | - | - | - |
Other Current Assets | 0.41 | 0.52 | 0.59 | 1.63 | 2 | 1.72 |
Total Current Assets | 48.86 | 51.87 | 6.15 | 10.77 | 9.45 | 29.39 |
Net Property, Plant & Equipment | 8.47 | 9.21 | - | - | - | - |
Other Intangible Assets | 0.21 | 0.22 | 15.4 | 17.27 | 19.14 | 22 |
Other Long-Term Assets | 0.16 | 0.6 | 0.04 | 0.04 | 7.3 | 6.69 |
Total Assets | 57.7 | 61.9 | 21.59 | 28.09 | 35.89 | 58.09 |
Accounts Payable | 4.68 | 4.28 | 15.07 | 4.33 | 3.76 | 4.93 |
Accrued Expenses | - | - | 0.36 | 0.69 | 0.37 | 0.23 |
Short-Term Debt | 0.68 | 0.85 | - | - | - | - |
Current Portion of Long-Term Debt | - | - | 0.63 | 1.8 | 1.84 | - |
Other Current Liabilities | 0.32 | 0.28 | 9.73 | 0.75 | 0.76 | 3.17 |
Total Current Liabilities | 5.68 | 5.4 | 25.8 | 7.57 | 6.73 | 8.33 |
Long-Term Debt | 1.95 | 2.29 | - | - | - | - |
Other Long-Term Liabilities | 0.19 | 0.16 | 5.81 | 8.47 | 10.89 | 11.91 |
Total Long-Term Liabilities | 2.14 | 2.45 | 5.81 | 8.47 | 10.89 | 11.91 |
Total Liabilities | 7.82 | 7.86 | 31.6 | 16.03 | 17.61 | 20.24 |
Common Stock | 137.31 | 137.25 | 101.64 | 97.45 | 84.48 | 80.29 |
Additional Paid-in Capital | - | - | - | - | - | 0.46 |
Accumulated Other Comprehensive Income | 0.01 | - | 3.47 | 3.68 | 2.41 | 1.3 |
Retained Earnings | -88.09 | -83.97 | -115.13 | -89.08 | -68.62 | -44.2 |
Total Common Shareholders' Equity | 49.23 | 53.28 | -10.02 | 12.05 | 18.28 | 37.85 |
Minority Interest | 0.66 | 0.77 | - | - | - | - |
Shareholders' Equity | 49.89 | 54.05 | -10.02 | 12.05 | 18.28 | 37.85 |
Total Liabilities & Equity | 57.7 | 61.9 | 21.59 | 28.09 | 35.89 | 58.09 |
Total Debt | 2.64 | 3.13 | 0.63 | 1.8 | 1.84 | 0 |
Net Cash (Debt) | 32.32 | 36.81 | 1.02 | 3.44 | 5.52 | 27.59 |
Net Cash Growth | -12.18% | 3496.73% | -70.29% | -37.60% | -79.99% | 214.78% |
Net Cash Per Share | 169.38 | 33.59 | 1.94 | 9.35 | 20.84 | 117.22 |
Book Value | 49.23 | 53.28 | -10.02 | 12.05 | 18.28 | 37.85 |
Book Value Per Share | 257.96 | 48.62 | -19.00 | 32.70 | 68.98 | 160.83 |
Tangible Book Value | 49.02 | 53.06 | -25.42 | -5.22 | -0.86 | 15.85 |
Tangible Book Value Per Share | 256.87 | 48.41 | -48.20 | -14.16 | -3.26 | 67.34 |